(19)
(11) EP 1 541 144 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.09.2011 Bulletin 2011/38

(45) Mention of the grant of the patent:
20.10.2010 Bulletin 2010/42

(21) Application number: 03741534.6

(22) Date of filing: 22.07.2003
(51) International Patent Classification (IPC): 
A61K 31/405(2006.01)
A61K 47/02(2006.01)
A61K 47/14(2006.01)
A61K 47/32(2006.01)
A61K 47/44(2006.01)
A61K 9/70(2006.01)
A61K 47/10(2006.01)
A61K 47/30(2006.01)
A61K 47/38(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/JP2003/009273
(87) International publication number:
WO 2004/010994 (05.02.2004 Gazette 2004/06)

(54)

INDOMETHACIN EXTERNAL PREPARATION

INDOMETHACIN-PRÄPARAT ZUR TOPISCHEN ANWENDUNG

PREPARATION D'INDOMETACINE A USAGE EXTERNE


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 29.07.2002 JP 2002219315

(43) Date of publication of application:
15.06.2005 Bulletin 2005/24

(73) Proprietor: Kowa Company, Ltd.
Nagoya-shi, Aichi 460-0003 (JP)

(72) Inventors:
  • SHIRAI, Hiroyuki c/o Kowa Company,Ltd. Fuji Rsrch.Labs.
    Shizuoka 417-8650 (JP)
  • NAKAI, Tatsuya c/o Kowa Company,Ltd. Fuji Rsrch.Labs.
    Shizuoka 417-8650 (JP)
  • SERIZAWA, Masami c/o Kowa Company,Ltd. Fuji Rsrch.Labs.
    Shizuoka 417-8650 (JP)
  • SHINODA, Yasuo c/o Kowa Company,Ltd. Fuji Rsrch.Labs.
    Shizuoka 417-8650 (JP)
  • INAGI, Toshio c/o Kowa Company,Ltd. Fuji Rsrch.Labs.
    Shizuoka 417-8650 (JP)

(74) Representative: Bannerman, David Gardner et al
Withers & Rogers LLP Goldings House 2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)


(56) References cited: : 
EP-A2- 0 055 029
JP-A- 5 271 075
JP-A- 59 227 818
JP-A- 2001 354 548
US-A- 4 474 798
JP-A- 1 279 831
JP-A- 10 182 458
JP-A- 62 061 918
JP-A- 2003 095 985
US-A- 4 545 992
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).